1. References
1. Montagna MT, Triggiano F, Barbuti G, Bartolomeo N, De Giglio O, Diella G, Lopuzzo M, Rutigliano S, Serio G, Caggiano G. Study on the In Vitro Activity of Five Disinfectants against Nosocomial Bacteria. International journal of environmental research and public health. 2019 Jan; 16(11):1895.
2. West AM, Teska PJ, Lineback CB, Oliver HF. Strain, disinfectant, concentration, and contact time quantitatively impact disinfectant efficacy. Antimicrobial Resistance and Infection Control. 2018 Dec; 7(1):49.
3. Xia J, Gao J, Tang W. Nosocomial infection and its molecular mechanisms of antibiotic resistance. Bioscience trends. 2016; 10(1):14-21.
4. Watanabe S, Ohnishi T, Yuasa A, Kiyota H, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Manabe M, Suzuki T. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. Journal of Infection and Chemotherapy. 2017 Aug 1; 23(8):503-11.
5. Yamagishi Y, Hagihara M, Kato H, Hirai J, Nishiyama N, Koizumi Y, Sakanashi D, Suematsu H, Nakai H, Mikamo H. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa. Chemotherapy. 2017; 62(2):105-10.
6. Scano A, Serafi G, Fais S, Bomboi S, Peri M, Ibba A, Girometta G, Orrù G, Rossi P, Sanna P, Coghe F. Antimicrobial susceptibility pattern to disinfectants in Pseudomonas aeruginosa strains isolated from dairy sheep breeds in Sardinia. Large Animal Review. 2019 Apr 18; 25(1):11-5.
7. Stefani S, Campana S, Cariani L, Carnovale V, Colombo C, Lleo MM, Iula VD, Minicucci L, Morelli P, Pizzamiglio G, Taccetti G. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. International Journal of Medical Microbiology. 2017 Sep 1; 307(6):353-62.
8. Ferris RA, McCue PM, Borlee GI, Glapa KE, Martin KH, Mangalea MR, Hennet ML, Wolfe LM, Broeckling CD, Borlee BR. Model of chronic equine endometritis involving a Pseudomonas aeruginosa biofilm. Infection and immunity. 2017 Dec 1; 85(12):e00332-17.
9. Argyraki A, Markvart M, Nielsen A, Bjarnsholt T, Bjørndal L, Petersen PM. Comparison of UVB and UVC irradiation disinfection efficacies on Pseudomonas Aeruginosa (P. aeruginosa) biofilm. InBiophotonics: Photonic Solutions for Better Health Care V 2016 Apr 27 (Vol. 9887, p. 988730). International Society for Optics and Photonics.
10. Lineback CB, Nkemngong CA, Wu ST, Li X, Teska PJ, Oliver HF. Hydrogen peroxide and sodium hypochlorite disinfectants are more effective against Staphylococcus aureus and Pseudomonas aeruginosa biofilms than quaternary ammonium compounds. Antimicrobial Resistance and Infection Control. 2018 Dec 1; 7(1):154.
11. ECDC 2018: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099 (18)30605-4/sec1 (accessed on 23 January 2019).
12. Rahimzadeh Torabi L, Doudi M, Golshani Z. The frequency of blaIMP and blaVIM carbapenemase genes in clinical Isolates of pseudomonas aeruginosa in Isfahan medical centers. medical journal of mashhad university of medical sciences. 2016; 59(3):139-47.
13.
14. Subedi D, Vijay AK, Willcox M. Study of Disinfectant Resistance Genes in Ocular Isolates of Pseudomonas aeruginosa. Antibiotics. 2018 Dec; 7(4):88.
15. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R. Global trends in resistance to antituberculosis drugs. New England Journal of Medicine. 2001 Apr 26; 344(17):1294-303.
16. Abdollahzadeh Fatemeh, Hakami Vala Mojdeh, Bagheri Bajestani Fatemeh, Bahar Mohammad Reza. Evaluation of ESBL Extended Beta Lactamase Production from Pseudomonas aeruginosa strains isolated from burn patients admitted in Shahid Motahari Hospital. Tehran Iran. 2011; 47-42: 1.
17. Damin Teb Rooz. Intra Hyvarocare.2019. Availablc at: www.daminteb.com
18. Gasparini R, Pozzi T, Magnelli R, Fatighenti D, Giotti E, Poliseno G, Pratelli M, Severini R, Bonanni P, De Feo L. Evaluation of in vitro efficacy of the disinfectant Virkon. European journal of epidemiology. 1995 Apr 1; 11(2):193-7.
19. Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N, Cirasola D, Aragones L, Coelho JR, Freitas AT, Marchi E, Moce L. Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrobial agents and chemotherapy. 2013 Aug 1; 57(8):3488-97.
20. Alzubeidi YS, Udompijitkul P, Talukdar PK, Sarker MR. Inactivation of Clostridium perfringens spores adhered onto stainless steel surface by agents used in a clean-in-place procedure. International journal of food microbiology. 2018 Jul 20; 277:26-33.
21. Webb HE, Brichta-Harhay DM, Brashears MM, Nightingale KK, Arthur TM, Bosilevac JM, Kalchayanand N, Schmidt JW, Wang R, Granier SA, Brown TR. Salmonella in peripheral lymph nodes of healthy cattle at slaughter. Frontiers in microbiology. 2017 Nov 9; 8:2214.
22. Uppal S, Bazzi A, Reynolds RK, Harris J, Pearlman MD, Campbell DA, Morgan DM. Chlorhexidine-alcohol compared with povidone-iodine for preoperative topical antisepsis for abdominal hysterectomy. Obstetrics and Gynecology. 2017 Aug 1; 130(2):319-27.
23. Koehler DA, Strevett KA, Papelis C, Kibbey TC. The impact of antibacterial handsoap constituents on the dynamics of triclosan dissolution from dry sand. Chemosphere. 2017 Nov 1; 186:251-6.
24. Olasehinde GI, Akinyanju JA, Ajayi AA. Comparative Antimicrobial Activity of Commercial Disinfectants with Naphtolics. Research Journal of Microbiology. 2008; 3(4):262-8.
25. El-Banna T, El-Aziz AA, Sonbol F, El-Ekhnawy E. Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production. Molecular biology reports. 2019 Jun 1; 46(3):3437-43.
26. Vijaya k, Aboody MS, Alfanaisan MK. Sandle T. In vitro susceptibility of multidrug resistant pseudomonas aeruginosa clinical isolates to common biocides. International Journal of Pharmaceutical Sciences and Research. 2016; 7(1): 110-116.
27. Houari A, Di Martino P. Effect of chlorhexidine and benzalkonium chloride on bacterial biofilm formation. Letters in applied microbiology. 2007 Dec; 45(6):652-6.
28. Olasehinde GI, Akinyanju JA, Ajayi AA. Comparative Antimicrobial Activity of Commercial Disinfectants with Naphtolics. Research Journal of Microbiology. 2008; 3(4):262-8.
29. Carson LA, Favero MS, Bond WW, Petersen NJ. Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl. Environ. Microbiol. 1972 May 1; 23(5):863-9.
30. Lotfipour F, Nahaee M, Milani M et al. Evaluation of the effect of several common hospital disinfectant products on patients with pseudomonas aeruginosa isolated from patients. Journal of Medical Sciences, Tabriz University of Medical Sciences, 2008; 72-67.
31. Gasparini R, Pozzi T, Magnelli R, Fatighenti D, Giotti E, Poliseno G, Pratelli M, Severini R, Bonanni P, De Feo L. Evaluation of in vitro efficacy of the disinfectant Virkon. European journal of epidemiology. 1995 Apr 1; 11(2):193-7.
2. Study on the In Vitro Activity of Five Disinfectants against Nosocomial Bacteria
3. Strain, disinfectant, concentration, and contact time quantitatively impact disinfectant efficacy
4. Nosocomial infection and its molecular mechanisms of antibiotic resistance
5. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan